FDA Approves ADHD Diagnostic Device

A brainwave-measuring device that could help diagnose kids with ADHD has been approved by the US Food and Drug Administration.  The device's creators earned the approval after conducting research showing that a 20-minute test on the device, when combined with standard ADHD diagnostic measures, increased the accuracy of doctors' diagnoses.  More on how the device works from the website PopSci.com:

The device detects two different types of brainwaves, theta and beta, and how frequently they occur. Kids with attention-deficit/hyperactivity disorder have more theta than beta brainwaves, compared to kids without ADHD.

The FDA approved the device, called the Neuropsychiatric Electroencephalogram-Based Assessment Aid or NEBA, for use with a full medical exam. In a statement, the director of the agency's Office of Device Evaluation, Christy Foreman, emphasized that the device has to work with other clinical measures.

To get their FDA approval, NEBA's creators performed a study with 275 kids with attention problems. The study, which the FDA didn't make public, found that adding a 20-minute NEBA test to standard diagnostic procedures helped doctors diagnose ADHD more accurately.

Comments

Be the first to comment!



Parents may receive compensation when you click through and purchase from links contained on this website.